Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 21st October 2020 from 07:00 AM to 07:00 PM (BST).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 28, 2020
Previous Article Next Article

Determination of prescribed and designer benzodiazepines and metabolites in influent wastewater

Author affiliations

Abstract

Benzodiazepines are important prescription pharmaceuticals used to help in the treatment of anxiety and sleep disorders. However, they also have a strong potential for abuse. In this respect, illicit benzodiazepines, i.e. not prescribed in Australia and designer benzodiazepines, which are new compounds that are not legally prescribed in any jurisdiction, have emerged in the illicit Australian market in recent years. Designer benzodiazepines are a new class of new psychoactive substances (NPS) and are particularly dangerous due to limited toxicity information and propensity to be mistaken for conventional benzodiazepines, leading to severe side effects and potentially death. It is therefore important to assess the prevalence of the use of these compounds in the community. The current work presents a validated liquid chromatography-mass spectrometry method for 20 prescribed and designer benzodiazepines and metabolites: 7-amino nimetazepam, alpha-hydroxy alprazolam, alprazolam, clonazepam, delorazepam, deschloroetizolam, diazepam, diclazepam, etizolam, flubromazepam, flunitrazepam, lorazepam, lormetazepam, meclonazepam, midazolam, nimetazepam, nitrazepam, oxazepam, pyrazolam and temazepam. Quetiapine, a prescription sedative drug that has been diverted for non-medical use, was also validated. Limits of quantification were predominantly below 10 ng L−1, except for the ubiquitous oxazepam, quetiapine and temazepam, which were between 75–300 ng L−1. Stability, recovery and matrix effects were also examined. Finally, this method was applied to influent wastewater from South Australia, which showed the presence of many benzodiazepines including the NPS etizolam.

Graphical abstract: Determination of prescribed and designer benzodiazepines and metabolites in influent wastewater

Back to tab navigation

Supplementary files

Article information


Submitted
18 Mar 2020
Accepted
26 Jun 2020
First published
30 Jun 2020

Anal. Methods, 2020,12, 3637-3644
Article type
Paper

Determination of prescribed and designer benzodiazepines and metabolites in influent wastewater

R. Bade, M. Ghetia, J. M. White and C. Gerber, Anal. Methods, 2020, 12, 3637
DOI: 10.1039/D0AY00560F

Social activity

Search articles by author

Spotlight

Advertisements